Abstract

Myopia has become a challenge for public health in the last decades due to the increase in its prevalence and its effect on the axial growth of the eye. The main concern about the myopia progression in the child population is due to the appearance of secondary pathologies of myopia in the adulthood. They have been developed various optical and pharmacological treatments in the last years to try to minimize the axial growth of the eye and therefore to try to prevent, to delay or to minimize the impact of pathologies associated to myopia that could provoke loss of vision.Within the optical treatments to control the axial growth progression, orthokeratology contact lenses, peripheral defocus soft contact lenses and ophthalmic lenses have been described. Other optical devices are also being developed that through the management of different wavelengths of light will serve as adjuvants for the myopia control.That presentation will try to show the scientific evidence on the efficacy and safety of the use of these treatments as well as to discuss the possible mechanisms of action to minimize the axial growth progression.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call